Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-04
1993-06-08
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 5142272, 514267, 514269, 514275, 514292, 514293, 514342, 514443, 514445, 514468, A01N 4340, A01N 4354, A61K 3144, A61K 31505
Patent
active
052179745
ABSTRACT:
Administration of a folate binding protein binding agent in conjunction with use of an antitumor agent which is an inhibitor of glycinamide ribonucleotide transformylase or other antifolate reduces the toxic effects of such agent and provides an enhanced therapeutic index.
REFERENCES:
patent: 4684653 (1987-08-01), Taylor et al.
patent: 4833145 (1989-05-01), Taylor et al.
patent: 4871743 (1989-10-01), Taylor et al.
patent: 4882334 (1989-11-01), Shih et al.
patent: 4902796 (1990-02-01), Taylor et al.
patent: 4946846 (1990-08-01), Nomura et al.
patent: 4996206 (1991-02-01), Taylor et al.
patent: 4997838 (1991-03-01), Akimoto et al.
patent: 5010194 (1991-04-01), Mueller et al.
Young, et al., Proc. Amer. Assoc. Cancer Res., 31, 1053 (1990).
Muggia, et al., Proc. Amer. Soc. Clinical Oncology, 1, 1285 (1990).
Grindey, et al., Proceedings of the 82nd Annual Meeting of the American Association for Cancer Research, vol. 32, p. 384, Abst. 1921 (1991).
Internal Eli Lilly and Company Memo Entitled "Cancer Progress Conference Trip Report".
Derwent Abstract 45319S (abstracting DT2063027).
Morgan, S. L., et al., Arthritis and Rheumatism 33: 9-18 (1990).
Straw, et al., Cancer Research, 44:3114-3119 (1984).
Temple, et al., Cancer Treatment Reports, 65:1117-1119 (1981).
Grindey Gerald B.
Shih Chuan
Eli Lilly and Company
Fontana Steven A.
Nutter Nathan M.
Whitaker Leroy
LandOfFree
Method for treating gar-transformylase tumors in mammals and red does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating gar-transformylase tumors in mammals and red, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating gar-transformylase tumors in mammals and red will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934245